Identification of the specific mechanisms downstream of the IFN-γ receptor that exacerbate Mtb infection in the lung might provide novel targets for host-directed therapy that aim to limit pathology-associated IFN-γ responses during TB. This evidence concerns the gene IFNG and tuberculosis.